Leeward Investments LLC MA Purchases 13,984 Shares of Ingevity Co. (NYSE:NGVT)

Leeward Investments LLC MA lifted its position in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 189,347 shares of the company's stock after purchasing an additional 13,984 shares during the period. Leeward Investments LLC MA owned 0.52% of Ingevity worth $7,716,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in NGVT. State Street Corp lifted its position in shares of Ingevity by 14.7% during the 3rd quarter. State Street Corp now owns 1,546,957 shares of the company's stock worth $60,331,000 after buying an additional 198,300 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in Ingevity by 1.7% during the third quarter. Thrivent Financial for Lutherans now owns 1,383,053 shares of the company's stock worth $53,939,000 after acquiring an additional 23,497 shares during the period. Segall Bryant & Hamill LLC lifted its holdings in Ingevity by 33.5% during the third quarter. Segall Bryant & Hamill LLC now owns 1,185,415 shares of the company's stock worth $46,231,000 after acquiring an additional 297,135 shares during the period. Royce & Associates LP boosted its position in Ingevity by 23.3% in the third quarter. Royce & Associates LP now owns 933,677 shares of the company's stock worth $36,413,000 after purchasing an additional 176,447 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Ingevity by 4.3% in the 3rd quarter. Geode Capital Management LLC now owns 815,661 shares of the company's stock valued at $31,817,000 after purchasing an additional 33,973 shares during the period. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Ingevity Stock Performance

Ingevity stock traded down $1.15 during midday trading on Thursday, reaching $47.72. The stock had a trading volume of 381,177 shares, compared to its average volume of 233,131. The firm has a market capitalization of $1.73 billion, a PE ratio of -4.03 and a beta of 1.64. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.29. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86. The firm's 50-day moving average price is $43.59 and its 200 day moving average price is $41.39.

Ingevity (NYSE:NGVT - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.66. The company had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. As a group, research analysts predict that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on NGVT. StockNews.com upgraded Ingevity from a "hold" rating to a "buy" rating in a research note on Thursday, February 20th. BMO Capital Markets upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $62.00 to $65.00 in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $55.17.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.